General Information
Version
6.2
Revision date
2022-11-15
Product name
Levorphanol (+)-tartrate salt dihydrate
CAS No.
5985-38-6
REACH No
A
Emergency telephone
+(46)-852503403
Icons in SDS
Company Information
company name
Merck Life Science AB
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H312+H332, H317, H334, H360
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H301 Toxic if swallowed. H312 + H332 Harmful in contact with skin or if inhaled. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H360 May damage fertility or the unborn child. H301 Toxic if swallowed. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H360 May damage fertility or the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P201 Obtain special instructions before use. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 3), H301 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 4), H312 Respiratory sensitization (Category 1), H334 Skin sensitization (Category 1), H317 Reproductive toxicity (Category 1B), H360 For the full text of the H-Statements mentioned in this Section, see Section 16.
